TREM2 and amyloidosis: Treatment with an anti-TREM2 agonist antibody has been shown to promote microglia activation and induce phagocytosis of amyloid in murine models of β-amyloidosis, reducing the amount of amyloid plaques and neuronal damage (Wang et al., 2020).